In contrast, b-Raf is more commonly mutated than A-Raf and c-Raf [9] in a human tumor, promoting tumour cell proliferation and survival by elevating kinase activity and stimulating downstream MEK–ERK signaling [10]. This evidence concerns the gene BRAF and neoplasm.